Article Details

CAR-T Therapies Cost Prohibitive for Diffuse Large B-Cell Lymphoma Treatment

Retrieved on: 2022-12-21 01:46:41

Tags for this article:

Click the tags to see associated articles and topics

CAR-T Therapies Cost Prohibitive for Diffuse Large B-Cell Lymphoma Treatment. View article details on HISWAI: https://www.managedhealthcareexecutive.com/view/car-t-therapies-cost-prohibitive-for-diffuse-large-b-cell-lymphoma-treatment

Excerpt

Antibody conjugates are monoclonal antibodies linked to cancer drug. CAR-T treatments are priced at about $400,000 and antibody conjugates in the ...

Article found on: www.managedhealthcareexecutive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up